Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Return on Sales (2023 - 2025)

Historic Return on Sales for Inhibrx Biosciences (INBX) over the last 3 years, with Q3 2025 value amounting to 120.31%.

  • Inhibrx Biosciences' Return on Sales rose 3772700.0% to 120.31% in Q3 2025 from the same period last year, while for Sep 2025 it was 120.31%, marking a year-over-year increase of 3772700.0%. This contributed to the annual value of 8437.86% for FY2024, which is 85710400.0% up from last year.
  • As of Q3 2025, Inhibrx Biosciences' Return on Sales stood at 120.31%, which was up 3772700.0% from 22.04% recorded in Q2 2025.
  • In the past 5 years, Inhibrx Biosciences' Return on Sales ranged from a high of 18580.11% in Q2 2024 and a low of 1568.4% during Q2 2023
  • For the 3-year period, Inhibrx Biosciences' Return on Sales averaged around 1590.87%, with its median value being 39.16% (2025).
  • Per our database at Business Quant, Inhibrx Biosciences' Return on Sales surged by 201485100bps in 2024 and then crashed by -186021500bps in 2025.
  • Over the past 3 years, Inhibrx Biosciences' Return on Sales (Quarter) stood at 56.29% in 2023, then tumbled by -750bps to 478.65% in 2024, then surged by 125bps to 120.31% in 2025.
  • Its Return on Sales was 120.31% in Q3 2025, compared to 22.04% in Q2 2025 and 16.11% in Q1 2025.